ID: ALA5281755

Max Phase: Preclinical

Molecular Formula: C17H16ClNO

Molecular Weight: 285.77

Representations

Canonical SMILES:  O=C(Cc1ccc(Cl)cc1)NC1Cc2ccccc2C1

Standard InChI:  InChI=1S/C17H16ClNO/c18-15-7-5-12(6-8-15)9-17(20)19-16-10-13-3-1-2-4-14(13)11-16/h1-8,16H,9-11H2,(H,19,20)

Standard InChI Key:  PBUKPJWEWUPZCI-UHFFFAOYSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 285.77

Molecular Weight (Monoisotopic): 285.0920

AlogP: 3.17

#Rotatable Bonds: 3

Polar Surface Area: 29.10

Molecular Species: NEUTRAL

HBA: 1

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 2

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: 3.74

CX LogD: 3.74

Aromatic Rings: 2

Heavy Atoms: 20

QED Weighted: 0.92

Np Likeness Score: -1.08

References

1. Dickson L, Teall M, Chevalier E, Cheung T, Liwicki GM, Mack S, Stephenson A, White K, Fosbeary R, Harrison DC, Brice NL, Doyle K, Ciccocioppo R, Wu C, Almond S, Patel TR, Mitchell P, Barnes M, Ayscough AP, Dawson LA, Carlton M, Bürli RW..  (2023)  Discovery of CVN636: A Highly Potent, Selective, and CNS Penetrant mGluR₇ Allosteric Agonist.,  14  (4): [PMID:37077399] [10.1021/acsmedchemlett.2c00529]

Source

Source(1):

• Scientific Literature